ArticleOPEN ACCESS

Treatment of rheumatic diseases and hepatitis B virus coinfection

Rheumatology International
DOI: 10.1007/s00296-014-3195-8
11Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We often encounter rheumatological patients coinfected with hepatitis B in daily practice. In this paper, we will discuss the basic characteristics of the virus of hepatitis B, course of infection, the safety of rituximab, tocilizumab, abatacept treatment and therapeutic recommendations in management of patients with rheumatic diseases.

Author supplied keywords

Cite

CITATION STYLE

APA

Felis-Giemza, A., Olesińska, M., Świerkocka, K., Więsik-Szewczyk, E., & Haładyj, E. (2015, March 1). Treatment of rheumatic diseases and hepatitis B virus coinfection. Rheumatology International. Springer Verlag. https://doi.org/10.1007/s00296-014-3195-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free